"Stem cell treatment" covers several distinct approaches that differ by where the cells are sourced from and how they are prepared. Understanding these differences helps patients have a more informed conversation with their medical team about which option may be relevant to their condition.
At StemCellCure, the choice of treatment type is never made in isolation. Our Stem Cell Biotechnology Specialist, Dr. Prashant Tyagi, evaluates the sourcing and laboratory-processing requirements of each option, while our General Physician, Dr. B. N. Singh, assesses whether a patient's overall health status is suited to the chosen approach — including, where relevant, baseline organ function and any pre-existing conditions that could affect treatment planning. This joint review between a regenerative-medicine specialist and a general physician is what allows us to move away from fixed, generic treatment packages and instead recommend an approach that is genuinely matched to the individual patient in front of us.
| Type | Source | Common Use | Notes |
|---|---|---|---|
| Autologous MSC | Patient's own bone marrow or adipose tissue | Orthopaedic, joint conditions | No donor-matching required |
| Allogenic MSC | Donor-derived, lab-expanded | Neurological, systemic conditions | Higher cell yield possible |
| UCMSC | Umbilical cord tissue | Wide range of chronic conditions | Most commonly used at StemCellCure |
| BMAC | Concentrated bone marrow aspirate | Orthopaedic injuries, fractures | Same-day, same-patient procedure |
| PRP | Patient's own blood plasma | Joint, soft-tissue support | Often combined with other therapies |
The right approach depends on the condition being treated, its stage, and the patient's overall health. Our team reviews diagnostic reports and medical history before recommending a specific treatment type and protocol — there is no one-size-fits-all package.
Cost varies by treatment type, number of sessions required, and diagnostic work-up needed. Rather than fixed "packages", StemCellCure provides a personalised quote once your medical reports have been reviewed — this ensures pricing reflects your actual treatment plan rather than a generic bundle.
Responsible for lab processing standards and matching each patient to the appropriate stem cell type and protocol based on individual case review.
There is no single "most effective" type — the right choice depends on the specific condition and patient factors. Our team will recommend an approach after reviewing your case.
Umbilical cord-derived MSCs are processed under controlled laboratory conditions and are one of the most commonly used sources in regenerative treatment today, though outcomes still vary by patient.
In some cases, combined approaches are used depending on the condition. This is determined case by case during your medical evaluation.
